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Introduction
Bariatric or metabolic surgery has been recommended as an effective treatment option for type 2 diabetes mellitus (T2DM) associated with obesity and suboptimal glycaemic control despite lifestyle change (1) . While most patients exhibit a significant improvement in T2DM
following surgery, remission of T2DM is not universal with a proportion of patients showing no significant improvement in glycaemic control or recurrence of T2DM at a later stage (2) (3) (4) .
To date, a definitive clinical and biochemical factor which predicts the resolution of T2DM
following bariatric surgery has not been identified (5) . Both Pories and Schauer suggested that T2DM was more likely to remain postoperatively if the duration of T2DM was greater than 5-8 years (6, 7) . It has also been observed that the rate of T2DM remission may be related to the percentage of excess weight loss (%EWL) achieved post-operatively (7) (8) (9) and that the %EWL is predictive of increased insulin sensitivity among subjects with and without T2DM (10, 11) . In addition, subjects with insulin treated T2DM and higher glycated haemoglobin (HbA 1c ) have a reduced likelihood of resolution (7) . Blackstone et al found that both the absence of insulin therapy preoperatively and a shorter duration of T2DM independently predicted remission (12) .
Total plasma insulin concentrations are in part dependent on the body mass of an individual and the degree of insulin resistance within an individual (13) . Since C-peptide is a direct measure of insulin production this may provide a more accurate measure of beta-cell insulin responsiveness to glucose (14) (15) (16) . An important determinant of T2DM remission is circulating levels of C-peptide that reflects pancreatic beta-cell reserve (17) . In T2DM, insulin levels may be supraphysiological due to a compensatory increase in insulin production associated with insulin resistance. However, in the later stages of T2DM, there is associated beta-cell dysfunction and failure leading to low insulin and C-peptide levels (18, 19) . Higher C-peptide A C C E P T E D M A N U S C R I P T 5 levels have been described in subjects with remission of T2DM compared to those without remission (20) suggesting that preoperative C-peptide evaluation may have a role in predicting the best patients for bariatric surgery. This has also been supported by other studies, but the role of C-peptide as a prognostic marker of T2DM remission has not translated to routine clinical practice (20) (21) (22) . Most of the studies to date have been conducted in Asian samples, a group who display variation in the T2DM phenotype (e.g. younger onset of diabetes, lower body mass index-BMI) compared to white Caucasian populations. Therefore these studies cannot be generalised. A recent publication reported that a fasting C-peptide level >2.9ng/mL [0.97nmol/L] provides a useful cut off for predicting the resolution of T2DM with a sensitivity of 78% and specificity of 72% in a Chinese sample of subjects (23) . A similar finding was noted in a Dutch study where complete resolution of T2DM was observed in 74% of patients with a preoperative fasting C-peptide levels >3.0 ng/mL (1.0 nmol/L). In contrast, none of the T2DM patients with preoperative fasting C-peptide <3.0 ng/mL (1.0 nmol/L) showed resolution (24) .
Our aim was to perform a focussed detailed study to investigate the predictive value of static (fasting) and dynamic C-peptide (2-hour, area under the curve-AUC) measurements during an oral glucose tolerance test (OGTT) in relation to resolution of T2DM 6 months after bariatric surgery regardless of operation type. From the outset our aim was not to examine different surgical techniques on the predictive use of C-peptide, but rather preoperative Cpeptide dynamics in relation to the resolution of T2DM.
Methods

Study participants
Approval for the study was obtained from the Local Research Ethics Committee (South West Wales; LREC reference 06/WMW02/7). Participants were identified and recruited from patients undergoing a planned bariatric surgical procedure. Entry criteria at the outset included: -both genders, age 20-65 years, body mass index (BMI) >40kg/m 2 and physically fit for surgery. All subjects either had previously diagnosed T2DM, or T2DM diagnosed during an oral 75g OGTT 1 month prior to surgery according to ADA criteria at that time (25, 26) . Participants with pre-existing diabetes treated with diet, oral agents, Glucagon-like peptide-1 (GLP-1) analogues or insulin were included. Participants with impaired glucose regulation comprising of either impaired fasting glycaemia [IFG] (5.6-6.9mmol/L) or impaired glucose tolerance [IGT] (2-hour glucose: 7.8-11.0mmol/L) (25) were excluded.
Study design
Participants were recruited prospectively and consecutively from the Bariatric Surgical clinic and were not blindly allocated to a surgical treatment option. As per local guidance at the time of recruitment, those with a BMI>50kg/m 2 were routinely offered bilio-pancreatic diversion (BPD), whereas those with a BMI below this were usually offered laparoscopic sleeve gastrectomy (LSG). LSG was a standard sleeve i.e. sleeve fashioned around a 32F bougie taken from 5cm proximal to the pylorus and up to the left crus. BPD involved a distal gastrectomy (as described by Scopinaro (27) ) and a 50cm common channel. A smaller proportion of participants had undergone laparoscopic adjustable gastric band (LAGB) and a Roux-en-Y gastric bypass (RYGB). LAGB was performed using the Pars Flaccida technique and RYGB by creating a small stomach pouch starting below the second major vessel on the lesser curve and 100/100cm alimentary and biliopancreatic limbs. All participants were recruited pre-operatively and seen post-operatively at 6 months where they underwent a standardized 75g OGTT (122mls of Polycal 61.9g/100ml of glucose, Nutricia Clinical Care,
Trowbridge, UK). Previous studies have demonstrated that the level of glycaemia reached 2 hours after 75g of glucose is closely related to the level of glycaemia after a standardized meal indicating an OGTT is a valid tool for revealing altered carbohydrate metabolism during a meal (28) . Insulin or oral hypoglycemic agents were omitted the night before the OGTT.
There was no standardized meal prescribed for the night before and subjects were asked to fast from the midnight before the test.
Baseline clinical and biochemical information
Baseline 
Measurements of insulin sensitivity
The Homeostasis Model Assessment (HOMA) was used to estimate steady state beta cell function (%B) and insulin sensitivity (%S) preoperatively and postoperatively were calculated using the Oxford University on-line calculator (http://www.dtu.ox.ac.uk/homacalculator, accessed 7 th May 2013) (29) . HOMA-IR is the reciprocal of HOMA %S. HOMA %S represent values of 100% in normal young adults when using currently available assays for insulin, specific insulin or C-peptide. The accuracy of
these measures has been validated and has been shown to correlate with clamp-derived indices of insulin sensitivity and secretion (30) . The fasting C-peptide to insulin ratio was calculated as an index of hepatic insulin clearance (31) .
Statistical analysis
A responder at 6 months was defined as a subject with a fasting plasma glucose <5.6mmol/L and HbA 1c <6.0% at 6 months. This is in line with established criteria for evaluating the resolution of diabetes 12 months after bariatric surgery based on fasting glucose and HbA 1c (32) . A non-responder was defined as a subject not achieving these criteria. A C C E P T E D M A N U S C R I P T 9 We used a logistic regression model to ascertain the effects of preoperative fasting C-peptide, BMI and duration of the diabetes in relation to diabetes outcome 6 months postoperatively. This is in line with a previous study by Dixon et al (23) . Diabetes outcome (responder vs nonresponder) was considered as the response variable and fasting C-peptide, BMI and duration of the diabetes as the predictors in the binary logistic regression model. We did not include the 2-hour C-peptide measurement since it was highly correlated with the fasting C-peptide and thus would increase the possibility of multicolinearity which would thereby violate the regression model's assumption. We also calculated sensitivity and specificity and the receiver operator characteristic (ROC) curve to check the predictive power of the regression model for predicting diabetes remission 6 months following surgery.
Results
Participant characteristics
The sample comprised of 24 white Caucasian subjects with T2DM with a mean age of 49.2 
Dynamic measures of glucose and insulin homeostasis
No differences were observed in the preoperative AUCs for glucose and insulin by responder status. Figure 1 shows C-peptide and insulin values during the preoperative 2-hour OGTT.
Significantly higher C-peptide levels were observed preoperatively at all the time points for responders. This is in keeping with significantly higher AUC 0-60 and AUC 0-120 for C-peptide (Table 2) for responders compared to non-responders. Figure 2 along with the coordinates table (Table 3 ). These show that the regression model predicts the remission of diabetes with a sensitivity of 85.7% and a specificity of 88.9%. Figure 3 shows the percentage of responders grouped by quartiles of fasting C-peptide, 2hour C-peptide and AUC 0-120 for C-peptide. No responders were seen in the lowest quartile for all of these measures. A linear association was observed for C-peptide AUC 0-120 across groups. Table 4 shows the sensitivity, specificity, positive and negative predictive values for predicting a responder. These are discrete calculations and are displayed taking the lower quartile value and the median values for each fasting C-peptide and 2-hour C-peptide. Using the lower quartile cut-off, both fasting C-peptide and 2-hour C-peptide had a sensitivity and negative predictive value of 100%. Using the median values the sensitivity and negative predictive values were approximately 70% and 60% respectively for both measures.
Relationships between C-peptide measurements and duration of diabetes and logistic regression analysis
Preoperative quartiles of static and dynamic C-peptide and diabetes resolution
Discussion
This small but focused study shows that preoperative static and dynamic C-peptide measurements aid in the prediction of T2DM resolution 6 months following bariatric surgery.
To our knowledge, no previous studies have examined preoperative AUCs for C-peptide in relation to T2DM resolution postoperatively. This examination of AUC is thus novel and worthy of reporting. We observed that fasting C-peptide was an independent predictor of T2DM resolution at 6 months. Of interest, a previous study by Dixon and colleagues (23) within a Chinese sample observed that a fasting C-peptide >2.9ng/mL (0.97nmol/L) provided predictive accuracy in predicting diabetes resolution. Aarts et al also observed similar cut-off level of fasting C-peptide 3ng/ml [>1nmo/L] in predicting T2DM resolution. We observed that no responders had a fasting C-peptide <2.5ng/mL (0.83nmol/L) (our lower quartile). We also observed that the duration of diabetes, static 2-hour C-peptide, AUC 0-60 and AUC 0-120 were different between responders and non-responders. These observations re-affirm the role of C-peptide as a prognostic marker. Of note, we observed that duration of diabetes was not correlated with any of the C-peptide markers, suggesting that caution may be required if duration of diabetes is to be used as an exclusive prognostic marker of T2DM resolution.
Logistic regression showed C-peptide, duration of diabetes and BMI were associated with response. The area under the ROC curve was 0.94 and a regression model predicted diabetes remission with a sensitivity of 85.7% and a specificity of 88.9%. This is in line with the previous study by Dixon et al in a Chinese sample of subjects (23) .
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Previously, low levels of C-peptide have been of use in identifying patients at risk of diabetes or with insulin deficiency such as type 1 diabetes and latent autoimmune diabetes in adults (33, 34) . Fasting C-peptide is a relatively simple test to perform and may therefore form an easy and accurate measure, which may aid in predicting the resolution of T2DM postoperatively and the need for potential T2DM related treatments postoperatively at 6 months. In addition the measurement of a 2-hour C-peptide also aids as a predictive method. Whilst the measurement of the AUC for C-peptide may not be practical as a routine test, our study shows good correlation between this the static measurements of C-peptide. Within our current study we did not examine the effects of C-peptide as a predictor of T2DM resolution in relation to different bariatric operations. Our aim was to examine the C-peptide measurements as predictors of response in a bariatric sample of subjects. Clearly different bariatric procedures are associated with different outcomes in relation to T2DM, however there is a growing body of evidence suggesting that LSG, BPD and RYGB may have a similar efficacy in the resolution of T2DM (26, 35) . Strengths of the current study include the well-detailed static and dynamic measurements performed within the white-Caucasian sample of subjects with T2DM. The main limitation of our study was the small number of patients included. Further studies are required with subjects from different cultural backgrounds after stratifying by types of surgery, and we would also suggest that such a study re-examines the subjects for longer periods post-operatively (e.g. 12 months and beyond).
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